Advanced Search

Richemont Sales Up Despite Asia Concerns

Nov 11, 2018 8:34 AM   By Rapaport News
Comment Comment Email Email Print Print Facebook Facebook Twitter Twitter Share Share

Richemont’s jewelry sales increased 12% in the first fiscal half, though signs of weakening in Asia raised investor concerns.

Jewelry proceeds at Cartier and Van Cleef & Arpels rose to EUR 2.45 billion ($2.77 billion) in the six months ending September 30, while watch sales grew 4% year on year to EUR 2.49 billion ($2.82 billion), Richemont reported Friday. At constant exchange rates, jewelry sales were up 15%.

Cartier’s Love brand and the Van Cleef & Arpels Alhambra collection were the best performers, while Asia Pacific and the Americas were the strongest regions for jewelry overall, the company noted.

Richemont chairman Johann Rupert cautioned, however, that consumer demand was increasingly volatile amid the uncertain economic and geopolitical environment. A typhoon in Hong Kong and the weak Chinese yuan dented tourist demand in September, finance director Burkhart Grund added, according the Financial Times.

Still, group sales jumped 21% to EUR 6.81 billion ($7.72 billion) for the period, while operating profit fell 3% to EUR 1.13 billion ($1.28 billion) due to acquisition costs. The company recently acquired online luxury retailer Yoox Net-A-Porter and Watchfinder, an omni-channel platform for pre-owned timepieces, which were both incorporated to the company during the period. Online sales accounted for 14% of the group's total revenue, management reported. 

Shares in Richemont fell more than 6% on Friday following the earnings announcement. 

Image: Cartier store, Paris. (Jakub Szypulka)
Tags: Burkhart Grund, Cartier, Cartier’s Love, Johann Rupert, Rapaport News, Richemont, Van Cleef & Arpels, Van Cleef & Arpels Alhambra
Similar Articles
Comments: (0)  Add comment Add Comment
Arrange Comments Last to First
© Copyright 1978-2022 by Rapaport USA Inc. All rights reserved. Index®, RapNet®, Rapaport®, PriceGrid™, Diamonds.Net™, and JNS®; are registered TradeMarks.
While the information presented is from sources we believe reliable, we do not guarantee the accuracy or validity of any information presented by Rapaport or the views expressed by users of our internet service.